IL6 and syringocystadenoma papilliferum: In the search for potential biomarkers for the prediction of sCAP, we found that BAL IL-1β (AUC 0.820), BAL IL-17 (AUC 0.779), and plasma IL-6 (AUC 0.778) could efficiently discriminate sCAP from nsCAP.